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Infections caused by Shiga toxin (Stx)-producing E. coli strains constitute a health
problem, as they are problematic to treat. Stx production is a key virulence factor
associated with the pathogenicity of enterohaemorrhagic E. coli (EHEC) and can result
in the development of haemolytic uremic syndrome in infected patients. The genes
encoding Stx are located on temperate lysogenic phages integrated into the bacterial
chromosome and expression of the toxin is generally coupled to phage induction
through the SOS response. We aimed to find new compounds capable of blocking
expression of Stx type 2 (Stx2) as this subtype of Stx is more strongly associated
with human disease. High-throughput screening of a small-molecule library identified
a lead compound that reduced Stx2 expression in a dose-dependent manner. We show
that the optimized compound interferes with the SOS response by directly affecting the
activity and oligomerization of RecA, thus limiting phage activation and Stx2 expression.
Our work suggests that RecA is highly susceptible to inhibition and that targeting
this protein is a viable approach to limiting production of Stx2 by EHEC. This type of
approach has the potential to limit production and transfer of other phage induced and
transduced determinants.
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INTRODUCTION
Enterohemorrhagic E. coli (EHEC) are a group of Shiga toxin (Stx) producing pathogenic E. coli
strains, which are associated with a broad spectrum of disease ranging from mild diarrhea to severe
haemorrhagic colitis and haemolytic uremic syndrome (HUS) (Paton and Paton, 1998). The first
recognition of an EHEC strain as a foodborne pathogen occurred in the US in 1982 during an
investigation of customers from a fast-food restaurant chain who had bloody diarrhea and severe
abdominal cramping with no fever (Riley et al., 1983). The E. coli serotype O157:H7, which had
not previously been associated with human disease, was isolated from infected individuals and
traced to contaminated hamburger meat (Riley et al., 1983). Shortly thereafter, E. coli O157:H7 was
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linked to the development of HUS (Karmali et al., 1983), a
disease predominantly affecting children and carrying a 5−10%
mortality rate. Since then, EHEC have been recognized as
responsible for hundreds of food and waterborne outbreaks, with
O157:H7 being the most prevalent serotype and the leading cause
of HUS in Europe and the United States (Tarr et al., 2005; Lim
et al., 2010).
The development of haemorrhagic colitis and HUS is
dependent on the production of Stx, a family of related toxins that
are essential for disease. Stx produced by EHEC strains are largely
differentiated into two types that share 55% sequence homology
(Fraser et al., 2004): Stx1, which differs from Shigella dysenteriae
Stx by a single amino acid, and Stx2, which is structurally similar
to Stx1 but antigenically distinct. Stx1 and Stx2 can be further
classified into several subtypes based on the sequence-based
relatedness of the proteins. These comprise three Stx1 subtypes
(1a, 1c, 1d) and seven Stx2 subtypes (2a, 2b, 2c, 2d, 2e, 2f, and 2g).
Shiga toxin are AB5 toxins, which bind via the B subunits
to the globotriaoslyceramide (Gb3) receptor, expressed on the
surface of vascular endothelial cells as well as Paneth cells in the
intestinal mucosa. B subunit binding leads to clathrin-dependent
endocytosis of the A-B subunits. Following endosomal processing
and trafficking to the golgi, the internalized A subunit cleaves
the 28S ribosomal RNA of the 60S ribosomal subunit, preventing
binding of elongation factor to the ribosome and thus inhibiting
protein synthesis, resulting in cell death by apoptosis (Bergan
et al., 2012).
The genes for Stx in E. coli are exclusively located on temperate
lysogenic phages that integrate into the genome of their host
bacterium. In the lysogenic state, Stx genes are replicated as an
integral part of the bacterial genome. Expression of the phage
genes occurs when the phage lytic cycle is activated by induction
of the SOS response. This triggers both the packaging of the genes
encoding Stx to be into phage particles, which are assembled and
released through lysis of the cell, and simultaneous production of
the Stx protein. The released Stx-encoding bacteriophages have
the potential to transduce other E. coli leading to dissemination
of this virulence phenotype.
The SOS response, a high-activity repair response to damage
of chromosomal DNA, is regulated by the interplay of the two
major proteins RecA, an ATP-dependent protein with DNA-
binding abilities, and LexA, the key repressor of SOS-induced
genes. Activation of RecA in response to DNA damage mediates
auto-cleavage of both LexA and prophage repressors, leading to
bacteriophage and Stx production.
The importance of Stx for EHEC pathogenesis has driven
efforts to develop novel compounds that interfere with this potent
toxin. In this work we designed a high throughput screen (HTS)
to identify compounds that preferentially affect expression of
stx2. We focused on Stx2 because studies in primates have shown
that administration of Stx2 alone can produce the symptoms of
HUS, while administration of Stx1 at the same dose does not. In
addition, epidemiological and in vitro studies demonstrate that
Stx2a is more likely to be associated with more serious human
disease (Persson et al., 2007; Manning et al., 2008; Fuller et al.,
2011). For the most effective lead compound, we then modified
key functional groups to reveal the components required for
activity. Based on our phenotypic studies, we hypothesized that
the inhibition of Stx expression might be due to inhibition of
the SOS response protein RecA, which we tested by a series of
biochemical and biophysical analyses. Our work demonstrates
that RecA is highly susceptible to inhibition and that targeting
this protein is a viable approach to limiting production of Stx2 by
EHEC.
MATERIALS AND METHODS
Chemical Synthesis
Tetrahydrofuran and dichloromethane were purified through
a Pure Solv 400-5MD solvent purification system (Innovative
Technology, Inc). Solvents were evaporated under reduced
pressure at 40◦C. All reactions described were performed under
argon atmosphere unless otherwise stated and monitored by thin
layer chromatography (TLC) with pre-coated TLC plates (Merck
Silica Gel 60 F254). Plates were visualized by UV light (254 nm),
iodine vapors or stained with anisaldehyde.
Details of the chemical synthesis are provided in
Supplementary Methods and an overview in Supplementary
Figure S1. Compounds were purified via flash column
chromatography using silica gel (FlurochemSilica LC 60A)
as the stationary phase. 1H NMR and 13C NMR spectra were
recorded at 400 and 100 MHz or at 500 and 125 MHz using either
a Bruker DPX Avance400 instrument or a Bruker Avancell500
instrument, respectively. IR spectra were obtained using a
Shimadzu FTIR-8400 spectrometer.
High-resolution mass spectra were obtained using a JEOL
JMS-700 mass spectrometer by electrospray and chemical
ionization operating at resolution of 15,000 full width at half
height.
High Throughput Screens
In preparation for screening experiments, plasmids pNY16,
pNY14, and pAJR145 were transformed into ZAP0273 (E. coli
Sakai stx-). These plasmids comprise the promoter region of
the gene encoding stx2, sulA and rpsM, respectively fused to
green fluorescent protein (GFP). The ChemBridge library of
17,500 chemically diverse compounds was screened with the
pNY16, pNY14, and pAJR145 reporter plasmids at 50 µM and
1% DMSO. Gain settings for the fluorescence readings were
optimized according to the zero percent effect (ZPE) values from
each assay. The library is organized into 56, 384-well plates. The
library was screened once with each assay and the Z′-values were
analyzed for each plate. Fluorescence levels were measured at
both t = 0 and at the assay end-points. Hits were defined as
compounds that affected the fluorescence signal by greater than 3
SDs.
Reporter Assays
Shiga toxin expression assays were performed using the
pstx2::GFP reporter fusion plasmid (pNY16). The plasmid was
transformed by electroporation into ZAP0273 and transformants
cultured overnight in LB medium containing 35 µg/mL
chloramphenicol. Overnight cultures were diluted into fresh
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LB at an OD600 of 0.08, and grown to an OD600 of 0.6 at
37◦C and 200 rpm. Compounds and mitomycin C (MMC,
1 µg/mL) were added at this point, and fluorescence and optical
density of cultures measured hourly. GFP fluorescence of 200 µL
aliquots was measured in a 96-well blank microtiter plate using a
FLUOstar Optima plate reader (BMG, Germany).
Induction and Measurement of Stx
Production in EHEC
Cultures of strain ZAP1620, a phage-type (PT) 21/28 EHEC
isolate, were cultured overnight in LB medium. After dilution
1/100, cultures were grown in the presence or absence of AHU3
(50 µM) to exponential phase (OD600 = 0.3–0.4) before phage
lysis was induced by the addition of mitomycin C (5µg/ml). Lysis
was allowed to proceed for 1.5 h after which cultures were filtered
(0.22 µm filter). Supernatant samples containing the toxin were
applied directly to a RIDASCREEN R© verotoxin (R-Biopharm)
96-well microtitre plate and assayed for toxin levels by ELISA
according to manufacturer guidelines.
Phage Transduction
Prophage strains E. coli JP10819 and S. aureus JP5011 (Quiles-
Puchalt et al., 2014) were grown in LB (E. coli) or TSB (S. aureus)
media at 37◦C, and 50 µM AHU3 and 2 µg/ml MMC added
at OD600 = 0.25. Cultures were then incubated at 32◦C with
80 rpm shaking for 4 h, followed by 21◦C without shaking for
16 h. Cultures were filtered through a 0.2 µM filter, and serially
diluted in phage buffer (100 mM NaCl, 0.5 M tris pH 7.8, 1 mM
MgSO4, 4 mM CaCl2). Hundred microliter of phage lysate was
added to 1 ml aliquots of MG1655 (E. coli) or RN4220 (S. aureus)
at an OD600 of 1.4. Samples were incubated without shaking at
37◦C for 30 min before addition of 3 ml 0.75% agar and plating
onto LB or TSB agar plates containing 6 µg/ml tetracycline and
1.7 mM sodium citrate. A negative control lacking addition of
phage lysate was also included to confirm the absence of phage
contamination. Colonies were subsequently counted to define the
number of transduction events per sample.
Colorimetric ATPase Assay
Colorimetric ATPase assays were performed using an Innova
Biosciences ATPase assay kit (#601-0120), and reactions carried
out following the manufacturer’s protocol, using 50 µM RecA
(NEB), 500 µM poly dT ssDNA (Midland Certified Reagent
Company) and 0.1−100 µM AHU3.
Sedimentation Equilibrium (SE)
Analytical Ultracentrifugation (AUC)
Analytical ultracentrifugation (AUC) was performed using an
Optima XL-I analytical ultracentrifuge (Beckman Coulter), with
samples in 50 mM Na-citrate, 5% (w/v) glycerol, pH 6.0, buffer
conditions optimal for maximizing the oligomeric state of RecA
(Brenner et al., 1990). Rotor speeds of 6, 10, and 14 k rpm
at a temperature of 4 and 20◦C were used, and absorbance
scans (280 nm) were taken every 3 h until analysis of the
scans with WinMATCH (Jeffrey Lary, University of Connecticut,
Storrs, CT, USA) indicated that equilibrium had been reached.
Sedimentation equilibrium data were analyzed with SEDPHAT
(Vistica et al., 2004) using the single species analysis model in
order to gain a model-independent measure of the whole-cell
weight average molecular mass.
RESULTS
Generation of Reporter Plasmids to
Facilitate HTS
The main aim of our study was to identify compounds that
specifically reduced Stx2 production by ZAP0273. To address
this, we designed a HTS for compounds that preferentially
affected expression of stx2, we also included a screen for
sulA expression to examine generic effects on SOS induction
(Mizusawa et al., 1983). The promoter regions of stx2 and sulA
were amplified from E. coli O157:H7 Sakai by PCR and cloned
into the XbaI site upstream of the GFP gene in plasmid pKC26,
thus creating transcriptional GFP reporter plasmids pNY16 and
pNY14. A further control, pAJR145, was also used, comprising
the promoter for rpsM, encoding the 30S ribosomal protein S13,
fused to GFP. Expression of this plasmid is closely linked to
bacterial growth rate. The use of GFP reporters allowed us to
use intact bacteria in the screen, which ensures that any active
compounds are likely to penetrate cells and reach intracellular
targets.
HTS for Compounds that Reduce Stx
Expression
To identify new compounds with the potential to reduce
expression of Stx we performed a HTS of the Chem-Bridge
library at the Laboratory for Chemical Biology, Umeå. The
library comprises 17,500 chemically diverse compounds that
have previously proven valuable for the identification of
novel therapeutics. Each compound was initially tested at a
concentration of 50 µM for the ability to suppress MMC-
induced expression of stx2::GFP in ZAP0273. Further details of
the HTS are provided in the Section “Materials and Methods”
and Figure 1. The primary selection criteria was for drugs
that inhibited pNY16 (stx2::GFP) fluorescence induction but
which had limited effects on pAJR145 (rpsm::GFP) and pBY14
(sulA::GFP) expression. However, compounds that showed
strong suppression of stx2::GFP expression and some suppression
of sulA::GFP were also taken forward for further investigation. In
total 76 hits, comprising 48 compounds that reduced fluorescence
in the pNY16 screen only and 28 compounds that reduced
fluorescence in pNY16 and pNY14 screens, were selected.
To validate the candidates and eliminate false positives,
compounds from the primary screens were studied in dose-
response (DR) experiments. Concentrations of compounds
ranging from 0.2 to 200 µM were prepared using 2-fold serial
dilutions. The DR experiments were performed with the pNY16,
pNY14, and pAJR145 reporters to evaluate inhibitor potency
and specificity. From the initial screen of 76 primary hits, 6
compounds showed a reproducible dose-dependent reduction
of MMC-induced stx::GFP expression (Supplementary Table S1).
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FIGURE 1 | Flow chart summarizing the screening process and DR experiments. A library of 17,500 compounds was screened using stx2::GFP, rpsm::GFP
and sulA::GFP reporter fusions. Seventy-six compounds that showed significant activity on stx2::GFP and suIA::GFP were identified from this initial screen, and
further dose-response assays narrowed this to six hits that reduced stx2::GFP expression in a dose-dependent manner. The single most potent compound was
taken forward for mechanistic studies.
FIGURE 2 | Structures of the compounds used in this study. Chemical
structures of the hit compound AHU1 (A), and its derivatives AHU2 (B), AHU3
(C), and AHU4 (D). The maleimide moiety was determined to be essential for
the molecule to be biologically active since its loss in the derivative AHU4 led
to inactivity.
The most effective of these was Hit2Lead compound ID
5324836 (Figure 2A), a phenyl pyrroledione henceforth called
AHU1. This compound displays dose-dependent suppression
of MMC-induced stx2::GFP expression (Figure 3A) with
no effect on growth rate at concentrations up to 50 µM
(Figure 3B). Increasing the AHU1 concentration to 100 µM
further reduced stx2 expression but also inhibited the growth
rate by 10%. As the genes encoding Stx are encoded on lytic
phages we also tested the ability of AHU1 to affect bacterial
lysis caused by phage mobilization. Addition of MMC to
ZAP0273 results in phage-mediated lysis that can be assayed
by monitoring the optical density of the culture. Lysis is
evident around 3 h after addition of MMC but is markedly
reduced by AHU1 at concentrations of 50 µm or greater
(Figure 3C).
Generation of a Focused Sub-Set of
Compounds to Study Structure-Activity
Relationship
AHU1 is a planar molecule composed of a maleimide group and
a morpholine moiety, connected by a benzene ring (Figure 2A).
In order to acquire information about the structure-activity
relationship of this compound, chemical derivatives of this
compound were synthesized. The morpholine group was chosen
for modification, as the presence of a heteroatom on the six-
membered ring readily facilitates chemical manipulation. Briefly,
the morpholine ring was replaced with its bioisostere piperazine
and the addition of a methyl group and a butyl chain on this
position gave the compounds AHU2 and AHU3, respectively
(Figures 2B,C). As we considered the maleimide part of the
compound was likely to be central to the activity of the molecule,
compound AHU4 was produced by the addition of a phenyl
group to the maleimide moiety (Figure 2D).
Effect of AHU1-4 on stx Expression
To determine the activity of AHU1-4 we used the stx2::GFP
reporter and monitored expression following addition of MMC.
Experiments were performed over a range of concentrations
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FIGURE 3 | Effect of AHU1 on stx2::GFP expression, growth rate and
lysis of E. coli. ZAP0273 transformed with pNY16 was cultured in the
presence of 25−200 µM AHU1, and induced with 1 µg/ml MMC. Expression
of stx2::GFP expression was measured by fluorescence, and bacterial growth
by OD600. (A) Inhibition of MMC-induced stx2::GFP expression by AHU1.
(B) Effect of AHU1 on bacterial growth in the absence of MMC. (C) Inhibition
of MMC-induced bacterial lysis by AHU1. Experiments were performed in
triplicate, and data plotted as the mean with standard deviation from the mean
displayed by error bars.
(10−200 µM) for all four compounds. The effectiveness of
AHU1-4 was directly compared by calculating the percentage
inhibition of stx2::GFP expression 6 h post-MMC induction,
at two concentrations of the compounds, 25 and 50 µM,
respectively. Addition of AHU4, containing the phenyl
substitution, resulted in no reduction in stx::GFP expression
thereby demonstrating the importance of the maleimide group
for activity. However, both AHU2 and AHU3 at 50µM produced
near-complete inhibition of stx2::GFP, which was significantly
(p < 0.05) higher than AHU1, which when used at the same
concentration inhibited expression by approximately 60%
FIGURE 4 | Inhibition of stx2::GFP expression and MMC-induced lysis
by AHU1-4. (A) Inhibition of stx2::GFP expression by 25 and 50 µM AHU1-4
at 6 h after addition of AHU1-4 and MMC. Data were calculated from triplicate
experiments and displayed as the mean inhibition with error bars showing the
standard deviation from the mean. Asterisks indicate a significant difference
(∗∗p < 0.001) from the original AHU1 concentration inhibition, determined by
Student’s unpaired t-test. (B) Inhibition of MMC-induced bacterial lysis after
addition of AHU1-4 and MMC. Experiments were performed in triplicate, and
data plotted as the mean with standard deviation from the mean displayed by
error bars.
(Figure 4A). AHU3 produced a greater increase in inhibition
at 25 µM when compared with AHU1. AHU2 and AHU3
also resulted in inhibition of phage-mediated bacterial lysis
(Figure 4B). As AHU3 was the most effective inhibitor out
of the four compounds, it was selected for use in all further
experiments.
Effect of AHU3 on Stx2 Production by
EHEC
To assess if AHU3 could impact on Stx2 production in EHEC we
directly assayed toxin production in ZAP1620, a wild-type strain
that is lysogenized with both Stx2a- and Stx2c-encoding phages
and was isolated from a human patient. ZAP1620 was cultured
to mid-exponential phase and MMC added to induce toxin
expression. Culture supernatants were isolated and the levels
of toxin assessed using an ELISA-based assay (RIDASCREEN R©
verotoxin, R-Biopharm). Data were calculated as a percentage of
expression compared with the positive control (100%), consisting
of inactivated Stx. Analysis of the supernatant of ZAP1620
showed strong MMC-dependent production of Stx2, at 85%
(±7%) activity compared with the positive control. Addition of
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FIGURE 5 | Reduction of MMC-induced phage production by 50 µM
AHU3. (A) Induction of JP10819 with 2 µg/ml MMC resulted in significantly
increased Stx phage production. Addition of 50 µM AHU3 produced a
significant decrease in phage production by both non-induced and
MMC-induced JP10819. The interaction between MMC and AHU3 was
determined to be significant (p < 0.001), implying that the reduction in phage
production by MMC-induced cells observed is not the result of the inhibitory
effect of AHU3 on bacterial growth. (B) Induction of JP5011 with 2 µg/ml
MMC resulted in significantly increased SLT phage production. Addition of
50 µM AHU3 produced a significant decrease in phage production by
MMC-induced JP5011. Asterisks indicate a significant difference (∗p < 0.05,
∗∗p < 0.001) in phage production between the groups indicated by capped
lines. The data shown are the average of triplicate individual experiments with
standard deviation from the mean displayed as error bars. Statistical
significance was determined by GLM analysis.
50 µM AHU3 reduced Stx2 expression to 47% activity (±3%)
compared with the positive control, demonstrating that AHU3
markedly inhibits Stx2 production in wild-type isolates.
Effect of AHU3 on Phage Transduction
Having demonstrated that AHU3 was indeed a bona fide inhibitor
of Stx expression, we focused our attention on understanding the
mechanism of action underpinning its activity. As AHU3 was
able to reduce phage-induced lysis of EHEC, we hypothesized
that it might be able to reduce the generation of transducible
phage particles. Phage transduction assays were performed using
E. coli JP10819 that carries only the lysogenic Stx2 prophage
φP27. This prophage contains a tetracycline resistance cassette
inserted into the stx2 toxin gene, and lacks other lysogenic
prophages. Phage production was induced by addition of MMC
in the presence and absence of 50 µM AHU3 and the resultant
phages produced were isolated by filtration. The non-lysogenic
strain E. coli MG1655 was used as a recipient for the phage
isolated from E. coli JP10819.
When no MMC was added to E. coli JP10819, basal levels
of Stx phage (104 phage/ml) were observed which increased
by four logs to 108 phage/ml following induction with MMC
(Figure 5A). The presence of 50 µM AHU3 resulted in a
significantly (P < 0.001) lower amount of phage produced with
a titre of 105 phage/ml; demonstrating that the production of
functional Stx phage particles is inhibited by AHU3.
As the AHU compounds appeared to inhibit phage-mediated
bacterial lysis, we next explored whether these drugs could inhibit
expression of other prophages. To evaluate their activity in Gram-
positive bacteria, Staphylococcus aureus JP5011, which carries the
φSLT phage containing a tetracycline resistance cassette inserted
into the plv gene, was used. When induced by 2 µg/ml MMC,
approximately 106 transductants/ml of JP5011 culture were
produced. In contrast, only 102 transductants/ml were generated
from uninduced JP5011. Treatment of the MMC-induced culture
with 50 µM AHU3 showed greater than a log fold reduction in
the number of transductants generated (Figure 5B).
Effect of AHU3 on RecA Expression and
Activity
Given that AHU3 inhibits expression and formation of functional
phage particles, we hypothesized that the compound may
function by affecting the activity of a protein involved in
the SOS response required for induction of phage expression.
When the SOS response is initiated, RecA binds to single
stranded DNA, forming filaments with ATPase activity. These
activated RecA filaments mediate autocleavage of the key SOS
response repressor LexA and prophage repressors, allowing
gene expression and production of assembled phage particles.
Therefore, one candidate target protein was RecA, the activity
of which can be measured using assays that quantify the amount
of free phosphate as a measure of ATP hydrolysis. This provides
an indirect measure of RecA nucleoprotein filament assembly
(Wigle and Singleton, 2007; Wigle et al., 2009; Sexton et al., 2010).
Using an ATPase assay (Innova Biosciences) we optimized
RecA and ssDNA concentrations at 250 nM and 5 µM,
respectively. DMSO, required for solubility of AHU3, was kept
at a final concentration (2%), which did not interfere with the
enzymatic activity of RecA. The ability of AHU3 to inhibit RecA-
mediated ATP hydrolysis was investigated at concentrations
between 0.1 and 100 µM, revealing a concentration-dependent
decrease in enzymatic activity. The data were used to generate a
dose-response curve (Figure 6A) which was used to determine
a relative IC50 value of 7.72 µM using GraphPad Prism. The
known RecA inhibitor curcumin (15) was used as a positive
control (Figure 6B) giving a relative IC50 of 6.69 µM. Since the
AHU4 compound showed no reduction in stx::GFP expression,
it was used as the negative control (Figure 6C). As expected,
AHU4 showed no dose-dependent effect on RecA-mediated ATP
hydrolysis
Effect of AHU3 on RecA oligomerization
Analytical ultracentrifugation allows the quantitative analysis of
macromolecules in solution. Previous studies have used AUC
sedimentation equilibrium experiments (SE) to analyze the
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FIGURE 6 | AHU3 inhibits RecA-mediated ATP hydrolysis.
(A) Dose-response curve for AHU3 showing the inhibition of ATPase activity
with 0.1−100 µM AHU3. Data are plotted as a percentage of the average
absorbance of the assay wells containing 0 µM AHU3. The curve exhibits an
IC50 value of 7.72 µM and a Hill slope of 0.109. (B) Dose-response curve for
curcumin showing the inhibition of ATPase activity with 0.1−100 µM
curcumin. The curve exhibits an IC50 value of 6.69 µM and a Hill slope of
2.400. (C) Dose-response curve for AHU4 showing no inhibition of ATPase
activity.
oligomerization of E. coli RecA, revealing monomers in reversible
equilibrium with trimers, hexamers and dodecamers (12). To
assess whether AHU3 affects the oligomerization dynamics of the
FIGURE 7 | AHU3 decreases RecA oligomerization. Whole cell weight
average molecular mass of RecA at AUC rotor speeds of 6, 10, and 14 k rpm.
Ten micrometer RecA was studied alone, in the presence of 0.5% DMSO, and
in the presence of 0.5% DMSO and 100 µM AHU3.
protein, we performed SE for RecA in the presence and absence of
AHU3. We also controlled for any influence of DMSO, included
as a solvent for AHU3, on protein behavior. The SE data were
analyzed with SEDPHAT using the species analysis model with
a single species, in order to gain a model-independent measure
of the whole-cell weight average molecular mass. The average
molecular mass of RecA oligomers in the absence of AHU3 and
DMSO was 556 kDa at 10,000 rpm and 404 kDa at 14,000 rpm
(Figure 7). When AHU3 was present in the sample, the average
molecular mass of RecA oligomers was greatly reduced at all rotor
speeds tested. The greatest changes were observed at 6,000 rpm,
with a 70% decrease in the average molecular mass compared
with untreated RecA (Figure 7). At 10,000 and 14,000 rpm,
the decreases were still marked, at 56 and 52%, respectively.
As a control we also compared the average molecular mass of
RecA with that of the same protein in the presence of DMSO
and found only very minor effects on RecA oligomerization.
These data demonstrate that AHU3 is affecting the formation of
larger oligomeric RecA species, resulting in an increase in lower
molecular mass oligomers.
DISCUSSION
In this study we employed a HTS to identify compounds with
an inhibitory effect on stx2 expression. We used bacterial GFP
reporter assays to ensure that any hits were active against intact
bacteria. Our selection criteria included a marked reduction
in stx2 expression, with minimal effects on growth rate or
off-target genes. When coupled with studies to determine the
dose-dependency of the response, only 6 compounds met our
criteria and we selected the best performing of these, AHU1, for
further study. Structure-activity studies resulted in the synthesis
of AHU3 that showed inhibition of stx2 gene expression and
phage production at a concentration that had minimal impact on
bacterial growth. Moreover, AHU3 was shown to be a genuine
inhibitor of Stx2 production and reduced toxin expression in a
wild-type EHEC O157 strain. However, the ability of AHU3 to
inhibit bacteriophage-mediated lysis, along with its activity in
both Gram-negative and Gram-positive strains indicated that the
activity of this compound was specific to an essential component
of the SOS response, rather than specifically on Stx production.
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Initiation of the SOS response is controlled by RecA, the
activity of which requires formation of ssDNA-bound helical
homopolymeric filaments (Chen et al., 2008). We therefore
hypothesized that RecA was the biological target of AHU3, as
inhibition of either activation of the monomeric form of this
protein or function of assembled RecA filaments would prevent
autocleavage of the repressors of SOS and phage genes.
The substitution of the AHU3 maleimide group with a phenyl
group, generating AHU4, caused the compound to become
inactive. Although natural maleimides are rare in nature, several
small compounds containing a modified maleimide moiety have
been identified in fungal and bacterial organisms. Pencolide,
produced by Penicillium strains, exhibits both bacteriostatic and
fungicidal activity (Lucas et al., 2007), while the fungal compound
farinomalein shows potent activity against plant pathogen
oomycetes (Putri et al., 2014). A Streptomycin showdoensis
maleimide compound, showdomycin, targets oxidoreductases,
and transferases involved in major cellular functions associated
with virulence, growth, and persistance in both Gram-negative
and Gram-positive strains (Böttcher and Sieber, 2010).
Maleimide moieties are well known as Michael acceptors, and
react readily with sulfhydryl groups of cysteine residues. It is
therefore highly likely that AHU3 reacts with RecA through
this addition-elimination mechanism, covalently binding to one
or more of the three cysteine residues present in RecA. This
mechanism of inhibition has been reported for other small
maleimide-based molecules; a phenyl-substituted maleimide
with anti-angiogenic activity shows potential as a candidate for
treatment of proliferative retinal disorders (Nowak-Sliwinska
et al., 2012), while a series of maleimide-based compounds with
inhibitory activity on monoamine oxidase B have shown promise
as a potential therapy for Parkinson’s disease (Manley-King
et al., 2009). Interestingly, a chloromaleimide-based compound
bearing a striking structural resemblance to AHU3 has been
reported as an inhibitor of RAD51, the human homologue of
RecA. This compound, RI-1, was shown to covalently bind a
single cysteine residue on a RAD51 located in the interface
required for monomer-monomer interaction (Budke et al.,
2012). In support of this hypothesis, we showed that AHU3
directly affected RecA in solution by reducing the formation of
larger oligomeric species. The effects of these compounds on
eukaryotic cells will form part of ongoing studies into the possible
application of these molecules to treat infection-based pathology
in relation of phage-induced toxins. However, this is dependent
on lack of cross reactivity for RAD51.
Several groups have suggested RecA as an attractive target
for inhibition and performed specific screens to identify suitable
compounds (Wigle and Singleton, 2007; Wigle et al., 2009; Sexton
et al., 2010; Peterson et al., 2012). Bacterial strains with RecA
deletion or inactivation have displayed an increased susceptibility
to a number of antimicrobials and a delayed emergence of
resistance compared with wild-type strains (Singh et al., 2010; Thi
et al., 2011; Alam et al., 2016). Additionally, the production and
release of bacteriophages initiated by the SOS response can result
in horizontal transmission of genes located on mobile genetic
elements, and therefore inhibition of this process may limit
the dissemination of virulence factors and antibiotic resistance
(Beaber et al., 2004).
While RecA inhibitors might not show a high degree of
selectivity due to the high conservation of RecA across bacteria,
they may have potential as drugs administered alongside other
more specific treatments to increase bacterial susceptibility to
anti-bacterials or limit development of antibiotic resistance.
Our work has demonstrated that RecA inhibition can also
significantly limit expression of prophage genes encoding
virulence factors, including Stx , emphasizing their additional
potential as therapies to limit bacterial production of key phage-
encoded virulence factors.
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